Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOSAIC: Chondroitin Sulphate in Knee OA
NCT01354145Phase 3Completed
- Sponsor
- Bioiberica
- Start
- Jun 2011
- Primary completion
- Sep 2014
- Modality
- Biomacromolecule, Polysaccharide, GAG (Glycosaminoglycan)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of chondroitin sulfate in knee osteoarthritis (OA), sponsored by Bioiberica. Primary endpoint: Cartilage Volume Loss of the Lateral Compartment at 24 months. Started Jun 2011; status: completed.
02
Drugs
chondroitin sulfate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01354145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01354145.